Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Cardiovascular outcomes of oral incretin-based drugs in type 2 diabetes: a GRADE-assessed meta-analysis of 67,679 patients
Frontiers in cardiovascular medicine, 2026;13:1884895
Visualizing Emerging Trends and Global Hotspots in Ozempic, Weight Loss, and Pancreatitis Research: A Scientometric Analysis
International journal of preventive medicine, 2026;17:103
Semaglutide in Atrial Arrhythmias: State of the Art and Future Perspectives
Journal of personalized medicine, 2026;16(10)
Treatment-Induced Neuropathy Presenting as Thoracic Radiculopathy and Abdominal Wall Protrusion After Marked Glycemic Improvement With Tirzepatide
Cureus, 2026;18(9):e117153
Tirzepatide Initiation in Lithium-Treated Bipolar Disorder: Renal Biomarker Trajectories and Lithium Safety Signals Over 12 Months in a Real-World Cohort
Human psychopharmacology;41(6):e70066
Peer Referral Pathways and 6-Month Outcomes in a Tirzepatide-Supported Digital Weight Loss Service: Retrospective Cohort Study
Journal of medical Internet research, 2026;28:e105583
New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
Combined Semaglutide and Sodium-Glucose Cotransporter-2 Inhibitor Use and Metabolic Outcomes in Chinese Adults With Diabetes: Post Hoc Analysis
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
Treatment With a GLP-1 Receptor Agonist Versus Reduction of the Gastrojejunal Anastomosis Diameter Using Endoscopic Argon Plasma Coagulation for Recurrent Weight Gain After Roux-en-Y Gastric Bypass
Obesity surgery, 2026
Non-Arteritic Anterior Ischaemic Optic Neuropathy Associated with Semaglutide use
Irish medical journal, 2026;119(8):160
Beyond weight loss: a narrative review of tirzepatide’s impact on muscle and lean mass in people with overweight and obesity
Current medical research and opinion, 2026;:1-12
Semaglutide for Treating Paediatric Craniopharyngioma-Related Obesity: A Multicentre Case Series
Diabetes, obesity & metabolism, 2026
Indirect comparative efficacy and safety of tirzepatide vs semaglutide for the treatment of obesity or overweight in patients without type 2 diabetes
International journal of obesity (2005), 2026
The dual incretin agonist tirzepatide blunts nicotine-induced behaviours and neurochemistry in male mice
British journal of pharmacology, 2026
Chronic semaglutide treatment attenuates cue-induced reinstatement of cocaine-seeking and cocaine-induced stereotypy in male and female rats
bioRxiv : the preprint server for biology, 2026
Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
Frontiers in medicine, 2026;13:1957367
Pancreatic and biliary safety signals of GLP-1 receptor agonists and tirzepatide: a disproportionality analysis of FAERS reports
Frontiers in endocrinology, 2026;17:1941948
Cardiometabolic therapy for rhythm control: a case report of refractory atrial fibrillation resolving after initiation of semaglutide for obesity
European heart journal. Case reports, 2026;10(10):ytag727
Reproductive and Gynecologic Effects of Glucagon-Like Peptide-1 Receptor Agonists in Women With Polycystic Ovary Syndrome: A Scoping Review
Cureus, 2026;18(9):e117072
Hypothalamic obesity in pediatric vs. adult craniopharyngioma: mechanisms, management, and cardiometabolic outcomes
Pituitary, 2026;29(5)